Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder

NCT03539900 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Binge-Eating Disorder

Interventions

DRUG: Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination
OTHER: Placebo

Sponsor

Yale University

Collaborators

[object Object]